The Cigna Group (CI)
- Previous Close
314.81 - Open
313.30 - Bid 315.22 x 800
- Ask 318.07 x 900
- Day's Range
306.67 - 318.75 - 52 Week Range
253.95 - 370.83 - Volume
2,354,418 - Avg. Volume
1,420,767 - Market Cap (intraday)
88.033B - Beta (5Y Monthly) 0.51
- PE Ratio (TTM)
30.03 - EPS (TTM)
10.54 - Earnings Date Jan 31, 2025 - Feb 4, 2025
- Forward Dividend & Yield 5.60 (1.77%)
- Ex-Dividend Date Dec 4, 2024
- 1y Target Est
393.61
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.
www.cigna.comRecent News: CI
View More
Related Videos: CI
Performance Overview: CI
Trailing total returns as of 11/1/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CI
View MoreValuation Measures
Market Cap
88.03B
Enterprise Value
114.95B
Trailing P/E
30.00
Forward P/E
9.88
PEG Ratio (5yr expected)
0.71
Price/Sales (ttm)
0.40
Price/Book (mrq)
2.09
Enterprise Value/Revenue
0.50
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
1.32%
Return on Assets (ttm)
2.80%
Return on Equity (ttm)
7.61%
Revenue (ttm)
229.75B
Net Income Avi to Common (ttm)
3.04B
Diluted EPS (ttm)
10.54
Balance Sheet and Cash Flow
Total Cash (mrq)
6.59B
Total Debt/Equity (mrq)
80.15%
Levered Free Cash Flow (ttm)
-2.88B
Research Analysis: CI
View MoreCompany Insights: CI
CI does not have Company Insights
Research Reports: CI
View MoreCigna Earnings: Solid Results and 2024 Outlook Despite Rising Medical Utilization
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense, and it recently won a deal with top-tier insurer Centene. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of September 2024.
RatingPrice TargetLowering target price to $339.00
THE CIGNA GROUP has an Investment Rating of BUY; a target price of $339.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of Medium; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of High.
RatingPrice TargetLowering target price to $349.00
THE CIGNA GROUP has an Investment Rating of BUY; a target price of $349.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of Medium; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of High.
RatingPrice TargetCigna-Humana: Merger Talks Reportedly Back On, but We Still See Antitrust Risks
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense, and it recently won a deal with top-tier insurer Centene. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, and the company operates mostly in the US with 18 million US medical members covered as of December 2023.
RatingPrice Target